UK Firms Give First Appraisal Of New Licensing & Access Pathway

Concrete examples of how the UK’s ILAP is working in practice are still thin on the ground, but the general experience of companies so far seems quite positive – albeit with caveats.

open door and heaven light
An innovation passport opens the door to the UK's new regulatory pathway • Source: Alamy

Member companies of the UK BioIndustry Association say they want the new Innovative Licensing and Access Pathway (ILAP) to remain open for products in both early and late-stage development, and that “partnership and engagement” among all the stakeholders involved are vital if the new pathway is to be successful.

Industry feedback on the ILAP, which was introduced by the regulator, the MHRA, in January this year, was shared at...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

EU Biosimilar Filings, Opinions And Approvals

 
• By 

<p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

EU Pharma Reform: What You Need to Know Now

 

As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

New EU Approvals

<p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography

Canada Cuts Red Tape With Single Ethics Review For Trials

A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.

Nancy Test Circulable Section Geography

 

This is a short description

Diversity Action Plans: What To Submit And When

 
• By 

With the deadline for comments on the US FDA’s draft guidance less than a month away, the Pink Sheet offers an infographic outlining what the agency is expecting in diversity action plans and when that might be implemented.